P2.01-102 Outcome of Patients with EGFR Exon 19 Mutation in a Phase III Randomized Trial Comparing Gefitinib to Gefitinib with ChemotherapyK. Prabhash,V. Noronha,V. Patil,A. Joshi,A. Chougule,A. Mahajan,A. Janu,R. Kumar,S. More,S. Goud,N. Kumar, N. Daware,A. Bhattacherjee,S. Shah,A. Yadav,S. BanavaliJOURNAL OF THORACIC ONCOLOGY（2019）引用 0|浏览26暂无评分关键词exon 19,EGFR,NSCLCAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
